Clinical Trials Browser

Phase 1/2 × Lymphoma, Extranodal NK-T-Cell × pegaspargase × Clear all

NCT04509466 2024-03-07

Clinical Study of Liposomal Mitoxantrone Hydrochloride Injection Combined With Pegaspargase in the Treatment of NKTCL

Phase 1/2 Terminated

Lymphoma, Extranodal NK-T-Cell